CGA-IGC 2025

Meet Ambry Scientific Experts at CGA-IGC! We’ll be at booth 6. Stop by or register using the link below.

• Tina Pesaran, MA, MS, CGC – Friday 10/10 2:50-3:10PM (coffee break) – As Vice President of Genomic Science at Ambry Genetics, Tina oversees a multidisciplinary team driving advancements in variant and gene assessment, medical informatics, and computational biology. Come chat with Tina about her commitment to evidence-based classification frameworks and Ambry’s mission to improve interpretation accuracy.
• Holly LaDuca, MS, CGC – Friday 10/10 2:50-3:10PM (coffee break) – In her role as a Clinical Strategy Manger, Holly works cross functionally with the Marketing, R&D, and Medical teams at Ambry to develop strategies that meet patient and provider needs in the hereditary cancer space. In particular, Holly is passionate about using translational and implementation science as a means to advance patient care. Meet Holly at the booth to learn more.
• Jennifer Herrera-Mullar, MS, CGC, DMA – Friday 10/10 2:50-3:10PM (coffee break) – Jeni is a Principal Clinical Scientist and a member of the Gene Team at Ambry. In this role, she evaluates gene-disease relationships of newly described and well-established genes with a focus on how evidence scoring must be adapted for common diseases like cancer. Come by the booth to learn from Jeni about pleiotropy, phenopy, and penetrance – oh my!

Classifi integrates multispecialty scientific expertise with technology to scale the delivery of high-quality genetic test results. The session will demonstrate how the integration of these components impacts test accuracy now and in the future, with a focus on hereditary gastrointestinal cancer conditions.​

​
Presented by:​
Holly LaDuca, MS, CGC, Clinical Strategy Manager, Ambry Genetics​

Jeni Herrera-Mullar, MGC, LCGC, DMA,  Principal Clinical Scientist, Ambry Genetics​

Tina Pesaran, MA, MS, CGC, Vice President, Genomic Science, Ambry Genetics